Treatment of intracerebral arteriovenous malformations with isobutyl 2-cyanoacrylate: initial clinical experience

Radiology. 1981 Jun;139(3):609-16. doi: 10.1148/radiology.139.3.6165036.

Abstract

From November 1976 to September 1979, 46 patients with intracranial arteriovenous malformations or fistulas participated in a clinical study using isobutyl 2-cyanoacrylate (IBCA), with tantalum, for palliative or preoperative occlusion of the blood supply to the abnormalities. Although failure to obtain satisfactory position of a functioning microcatheter precluded deposition of IBCA 10 times, a total of 51 of a possible 62 feeding vessels were occluded with the tantalum-impregnated glue. The technique, results, and complications are discussed in light of the clinical follow-up, which varied from 12 to 48 months.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Arteriovenous Malformations / diagnostic imaging
  • Arteriovenous Malformations / therapy*
  • Bucrylate / administration & dosage*
  • Child
  • Cyanoacrylates / administration & dosage*
  • Embolization, Therapeutic / methods*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Palliative Care
  • Postoperative Complications
  • Tantalum
  • Tomography, X-Ray Computed

Substances

  • Cyanoacrylates
  • Bucrylate
  • Tantalum